Inventiva IVA
NASDAQ IVA
$4.01 +0.06 (+1.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Inventiva (IVA) Return on Sales [ROS] (2020 - 2021)

Updated

Inventiva's Return on Sales [ROS] came in at -3145.51% for FY2025, down 2084.86 percentage points from -1060.64% in FY2024.

Analysis

Inventiva (IVA) Return on Sales [ROS] (2020 - 2021) Analysis & Trends

Going back to FY2018, Inventiva's Return on Sales [ROS] data covers 8 years.

  • Return on Sales [ROS] has declined in each of the last three years, though with a five-year change of +4843.20 percentage points (FY2020 to FY2025).
  • The FY2025 figure represents the lowest annual Return on Sales [ROS] since FY2020.
  • Per Business Quant, earlier years put Return on Sales [ROS] at -1060.64% in FY2024 (-472.96 pp), -587.68% in FY2023 (-118.76 pp), -468.92% in FY2022 (+773.66 pp) and -1242.58% in FY2021 (+6746.13 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Inventiva 763.29 Mn 38.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -21,021.54%
Mar 31, 2021 -13,435.14%
Jun 30, 2020 -11,972.97%
Mar 31, 2020 -7,821.84%
API Access

Inventiva Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IVA&period=max&api_key=YOUR_API_KEY